ArticleJournal of bone oncology2019

CXCR4 in human osteosarcoma malignant progression. The response of osteosarcoma cell lines to the fully human CXCR4 antibody MDX1338.

Serena Pollino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.